Quarterly report pursuant to Section 13 or 15(d)

Major Customers (Details Narrative)

v3.7.0.1
Major Customers (Details Narrative) - Customers Two [Member]
3 Months Ended
Mar. 31, 2017
USD ($)
Breathlyzers
Mar. 31, 2016
USD ($)
Breathlyzers
Concentration risk, percentage 10.00% 10.00%
Concentration risk, number of customer | Breathlyzers 2 2
Due from customers | $ $ 397,523 $ 500,742
Sales Revenue, Net [Member]    
Concentration risk, percentage 67.00% 74.00%